Gotti E - Search Results

1

Effect of dietary proteins and lipids in patients with membranous nephropathy and nephrotic syndrome.

D'Amico G, Remuzzi G, Maschio G, Gentile MG, Gotti E, Oldrizzi L, Manna G, Mecca G, Rugiu C, Fellin G. D'Amico G, et al. Among authors: gotti e. Clin Nephrol. 1991 Jun;35(6):237-42. Clin Nephrol. 1991. PMID: 1873936 Clinical Trial.

2

Post-transplant Kaposi's sarcoma.

Gotti E, Remuzzi G. Gotti E, et al. J Am Soc Nephrol. 1997 Jan;8(1):130-7. doi: 10.1681/ASN.V81130. J Am Soc Nephrol. 1997. PMID: 9013458 Review. No abstract available.

3

Abdominal pain and acute nephritis in a man with a recent renal transplant.

Gotti E, Abbate M, Ferrante P, Remuzzi G. Gotti E, et al. J Nephrol. 1998 Jul-Aug;11(4):196-8. J Nephrol. 1998. PMID: 9702870

4

Platelet function in patients on maintenance hemodialysis: depressed or enhanced?

Remuzzi G, Benigni A, Dodesini P, Schieppati A, Gotti E, Livio M, Mecca G, Donati B, de Gaetano G. Remuzzi G, et al. Among authors: gotti e. Clin Nephrol. 1982 Feb;17(2):60-3. Clin Nephrol. 1982. PMID: 7067167

5

Clinical problem solving. The girl with the curl.

Remuzzi G, Gotti E. Remuzzi G, et al. Among authors: gotti e. N Engl J Med. 1995 Oct 5;333(14):928-31. doi: 10.1056/NEJM199510053331409. N Engl J Med. 1995. PMID: 7666881 No abstract available.

6

Urinary excretion of platelet activating factor in patients with immune-mediated glomerulonephritis.

Noris M, Benigni A, Boccardo P, Gotti E, Benfenati E, Aiello S, Todeschini M, Remuzzi G. Noris M, et al. Among authors: gotti e. Kidney Int. 1993 Feb;43(2):426-9. doi: 10.1038/ki.1993.62. Kidney Int. 1993. PMID: 8441238 Free article.

7

A logistic-regression model provides novel guidelines to maximize the anti-acute rejection properties of cyclosporine with a minimum of toxicity.

Perna A, Gotti E, de Bernardis E, Perico N, Remuzzi G. Perna A, et al. Among authors: gotti e. J Am Soc Nephrol. 1996 May;7(5):786-91. doi: 10.1681/ASN.V75786. J Am Soc Nephrol. 1996. PMID: 8738815

8

Early ganciclovir therapy effectively controls viremia and avoids the need for cytomegalovirus (CMV) prophylaxis in renal transplant patients with cytomegalovirus antigenemia.

Gotti E, Suter F, Baruzzo S, Perani V, Moioli F, Remuzzi G. Gotti E, et al. Clin Transplant. 1996 Dec;10(6 Pt 1):550-5. Clin Transplant. 1996. PMID: 8996777

9

Hyperparathyroidism does not influence the abnormal primary haemostasis in patients with chronic renal failure.

Viganò G, Gotti E, Comberti E, Giangrande A, Trevisan R, Remuzzi G. Viganò G, et al. Among authors: gotti e. Nephrol Dial Transplant. 1989;4(11):971-4. doi: 10.1093/ndt/4.11.971. Nephrol Dial Transplant. 1989. PMID: 2516889

10

Pharmacokinetics help optimizing mycophenolate mofetil dosing in kidney transplant patients.

Cattaneo D, Gaspari F, Ferrari S, Stucchi N, Del Priore L, Perico N, Gotti E, Remuzzi G. Cattaneo D, et al. Among authors: gotti e. Clin Transplant. 2001 Dec;15(6):402-9. doi: 10.1034/j.1399-0012.2001.150607.x. Clin Transplant. 2001. PMID: 11737117

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

119 results

Search Page

Filters